Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Haukeland University Hospital | OTHER |
Not provided
Not provided
Not provided
The goal of this randomised study is comparison of wire assisted balloon mitral valvulotomy to standard Inoue balloon technique on patients with rheumatic mitral stenosis. The main question it aims to answer is whether procedure time is reduced using the wire assisted method. Participants will be randomized to one of the two methods.
Background: Rheumatic valvular disease, a chronic sequela of acute rheumatic fever, is a leading cause of cardiovascular mortality in developing countries. The available options of management include surgical treatment and balloon valvulotomy. Among various forms of rheumatic valvular lesions, severe mitral stenosis with favorable morphology can be successfully treated by balloon valvulotomy.
Methods: The study is a randomized controlled trial with intervention in both arms.
The objective of this study is to compare procedural time as a primary end point.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| standard Inoue balloon technique | Active Comparator | Those randomized to the standard care will undergo the procedure using the contemporary Inoue balloon system (Toray Industries, Japan), which is available in 4 sizes: 24, 26, 28 and 30 mm. |
|
| wire assisted crossing | Active Comparator | The procedure is performed on a similar fashion until atrial septal entry. Once the atrial wall is traversed, and the Mullins sheath is within the left atrium, the mitral valve is crossed with a flexible 0.032- or 0.035 in- 145 cm J-tipped wire. This step could be assisted by a steerable sheath. Once the mitral valve is crossed, the initial wire will be exchanged with a looped stiff wire (Safari or similar) to the left ventricle by use of a 5/6 f pigtail catheter. A commercially available balloon is used to perform the valvulotomy/commissurotomy procedure. Choice of balloon size is made following the formula: Balloon size = patient height (cm)/10 + 10. Fine tuning of the balloon size will be performed peri-operative based on transesophageal echo findings. Use of a separate stiff wire placed in the left atrium/pulmonary vein to ease passage through the atrial septum is left to the discretion of the operator based on the anatomical challenges faced during the procedure. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Percutaneous Balloon Mitral Valvulotomy | Device | Stenotic mitral valve will be dilated to open the commissures |
|
| Measure | Description | Time Frame |
|---|---|---|
| Reduction in procedure duration | procedure time in minutes | day 1 |
| Measure | Description | Time Frame |
|---|---|---|
| procedure failure | failed procedure after lengthy attempt | day 1 |
| Measure | Description | Time Frame |
|---|---|---|
| mortality | short and long term survival | 30 days |
| mortality | short and long term survival | 3 months |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Nigussie Bogale, MD, PhD | Haukeland University Hospital, Bergen, Norway | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Tikur Anbessa Specialized Hospital | Addis Ababa | Addis Ababa | 2500 | Ethiopia |
all collected IPD, all IPD that underlie results in a publication
November 2023 through december 2026
application must be submitted and signed electronically. The study team will asess the submitted proposals.
Not provided
| ID | Term |
|---|---|
| D012214 | Rheumatic Heart Disease |
| ID | Term |
|---|---|
| D012213 | Rheumatic Fever |
| D013290 | Streptococcal Infections |
| D016908 | Gram-Positive Bacterial Infections |
| D001424 | Bacterial Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Hospitalization for heart failure | hospitalization for worsening heart failure | 2 year |
| Procedure related neurological events | new neurological events | day 1 |
| Procedure related neurological events | new neurological events | 30 days |
| Vascular complications requiring intervention | transfusion requiring bleeding or vascular complication requiring percutaneous or surgical intervention | day 1 |
| new arrythmia | previously non existing arrythmia registered after intervention | day 1 |
| new bradyarrythmia | new bradyarrythmia requiring device intervention | day 1 |
| D001423 | Bacterial Infections and Mycoses |
| D007239 | Infections |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |